MedTrace Logo

RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma

NCT03320980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-10-25

No results posted yet for this study

Summary

Unsatisfactory immediate outcomes of Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in surgery of cholangiocarcinoma suggested that patients with biliary cancer should not be treated by ALPPS. Short-term results of ALPPS variants with reduced surgical trauma on the first stage in patients with cholangiocarcinoma were not yet estimated. The objective of the study was estimation of the short-term results of split-in-situ resection with radio-frequency ablation (RFA) instead of liver partition on the first stage (RALPPS) in patients with hilar (h-CCA) and intrahepatic (i-CCA) cholangiocarcinoma compared with portal vein embolization (PVE).

Conditions

  • Hilar Cholangiocarcinoma
  • Intrahepatic Cholangiocarcinoma

Interventions

PROCEDURE

RALPPS

RALPPS: split-in-situ resection with radio-frequency ablation (RFA) instead of liver partition on the first stage and major liver resection on the second stage

PROCEDURE

portal vein embolization + major liver resection

PVE on the first stage and major liver resection on the second stage

Sponsors & Collaborators

  • Moscow Clinical Scientific Center

    lead OTHER

Principal Investigators

  • Mikhail Efanov · Moscow Clinical Scientific Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-15
Primary Completion
2017-09-20
Completion
2017-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320980 on ClinicalTrials.gov